-
1
-
-
0024603105
-
Prevalence of ''significant'' hypertension in junior high school-aged children: The Children and Adolescent Blood Pressure Program
-
Sinaiko AR, Gomez-Marin O, Prineas RJ. Prevalence of ''significant'' hypertension in junior high school-aged children: The Children and Adolescent Blood Pressure Program. J Pediatr. 1989;114:664-669.
-
(1989)
J Pediatr.
, vol.114
, pp. 664-669
-
-
Sinaiko, A.R.1
Gomez-Marin, O.2
Prineas, R.J.3
-
2
-
-
0026772873
-
Predicting hypertension in childhood: Value of blood pressure measurement and family history
-
Grobbee DE. Predicting hypertension in childhood: Value of blood pressure measurement and family history. J Am Coll Nutr. 1992;11(suppl):S55-S59.
-
(1992)
J Am Coll Nutr.
, vol.11
, Issue.SUPPL.
-
-
Grobbee, D.E.1
-
3
-
-
0030603359
-
Hypertension in children
-
Sinaiko A. Hypertension in children. N Engl J Med. 1996;335: 1968-1973.
-
(1996)
N Engl J Med.
, vol.335
, pp. 1968-1973
-
-
Sinaiko, A.1
-
4
-
-
34248549564
-
Prevalence of hypertension and pre-hypertension among adolescents
-
McNiece KL, Poffenbarger TS, Turner JL, et al. Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr. 2007; 150:640-644.
-
(2007)
J Pediatr.
, vol.150
, pp. 640-644
-
-
McNiece, K.L.1
Poffenbarger, T.S.2
Turner, J.L.3
-
5
-
-
34748864742
-
High blood pressure trends in children and adolescents in national surveys, 1963to 2002
-
Din-Dzietham R, Liu Y, Bielo MV, et al. High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation. 2007;116:1488-1496.
-
(2007)
Circulation.
, vol.116
, pp. 1488-1496
-
-
Din-Dzietham, R.1
Liu, Y.2
Bielo, M.V.3
-
6
-
-
2342501856
-
Trends in blood pressure among children and adolescents
-
Muntner P, He J, Cutler JA, et al. Trends in blood pressure among children and adolescents. JAMA. 2004;291:2107-2113.
-
(2004)
JAMA
, vol.291
, pp. 2107-2113
-
-
Muntner, P.1
He, J.2
Cutler, J.A.3
-
7
-
-
21344460757
-
Characteristics of children with primary hypertension seen at a referral center
-
Flynn JT, Alderman MH. Characteristics of children with primary hypertension seen at a referral center. Pediatr Nephrol. 2005;20:961-966.
-
(2005)
Pediatr Nephrol.
, vol.20
, pp. 961-966
-
-
Flynn, J.T.1
Alderman, M.H.2
-
8
-
-
37249045898
-
Ability of blood pressure to predict left ventricular hypertrophy in children with primary hypertension
-
Brady TM, Fivush B, Flynn JT, et al. Ability of blood pressure to predict left ventricular hypertrophy in children with primary hypertension. J Pediatr. 2008;152:73-78, 78.e1.
-
(2008)
J Pediatr.
, vol.152
, Issue.73-78
-
-
Brady, T.M.1
Fivush, B.2
Flynn, J.T.3
-
9
-
-
64349095623
-
Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents
-
Liberman JN, Berger JE, Lewis M. Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents. Arch Pediatr Adolesc Med. 2009;163:357-364.
-
(2009)
Arch Pediatr Adolesc Med.
, vol.163
, pp. 357-364
-
-
Liberman, J.N.1
Berger, J.E.2
Lewis, M.3
-
10
-
-
32944464636
-
Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden
-
Lawes CM, Vander Hoorn S, Law MR, et al. Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden. J Hypertens. 2006;24:423-430.
-
(2006)
J Hypertens.
, vol.24
, pp. 423-430
-
-
Lawes, C.M.1
Vander Hoorn, S.2
Law, M.R.3
-
11
-
-
3442901072
-
The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents
-
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents 4th Report
-
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 suppl 4th Report):555-576.
-
(2004)
Pediatrics
, vol.114
, Issue.2 SUPPL.
, pp. 555-576
-
-
-
12
-
-
70350310100
-
Strict blood-pressure control and progression of renal failure in children
-
Wühl E, Trivelli A, Picca S, et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med. 2009;361: 1639-1650.
-
(2009)
N Engl J Med.
, vol.361
, pp. 1639-1650
-
-
Wühl, E.1
Trivelli, A.2
Picca, S.3
-
13
-
-
44649196549
-
Would preemptive therapy in childhood prevent cardiovascular disease?
-
Portman RJ, Nesbitt S. Would preemptive therapy in childhood prevent cardiovascular disease? J Clin Hypertens (Greenwich). 2007;9:739-741.
-
(2007)
J Clin Hypertens (Greenwich).
, vol.9
, pp. 739-741
-
-
Portman, R.J.1
Nesbitt, S.2
-
14
-
-
0035021702
-
Pediatric use of antihypertensive medications: Much more to learn
-
Flynn JT. Pediatric use of antihypertensive medications: Much more to learn. Curr Ther Res Clin Exp. 2001;62:314-328.
-
(2001)
Curr Ther Res Clin Exp.
, vol.62
, pp. 314-328
-
-
Flynn, J.T.1
-
15
-
-
84855651091
-
-
United States Food and Drug Administration. Pediatric labeling changes through September 28, 2010. Available at: Accessed October 26,2010
-
United States Food and Drug Administration. Pediatric labeling changes through September 28, 2010. Available at: Http://www.fda.gov/downloads/ ScienceResearch/SpecialTopics/PediatricTherapeuticsResearch/UCM163159. pdf. Accessed October 26, 2010.
-
-
-
-
16
-
-
0002886046
-
Renin and angiotensin
-
In: Brunton LL, Lazo JS, Parker KL, eds. 11th ed. Columbus, OH: McGraw Hill, Inc. Available at: Accessed: October 26, 2010
-
Jackson EK. Renin and Angiotensin. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th ed. Columbus, OH: McGraw Hill, Inc. Available at: Http:// www.accessmedicine.com. Accessed: October 26, 2010.
-
Goodman & Gilman's The Pharmacological Basis of Therapeutics
-
-
Jackson, E.K.1
-
17
-
-
0021848390
-
Efficacy of captopril in the treatment of severe childhood hypertension: Report of the International Collaborative Study Group
-
Mirkin BL, Newman TJ. Efficacy of captopril in the treatment of severe childhood hypertension: Report of the International Collaborative Study Group. Pediatrics. 1985;75:1091-1100.
-
(1985)
Pediatrics.
, vol.75
, pp. 1091-1100
-
-
Mirkin, B.L.1
Newman, T.J.2
-
18
-
-
0022520692
-
Antihypertensive drug therapy with captopril in children and adolescents
-
Sinaiko AR, Kashtan CE, Mirkin BL. Antihypertensive drug therapy with captopril in children and adolescents. Clin Exp Hypertens. 1996;8A: 829-839.
-
(1996)
Clin Exp Hypertens.
, vol.8 A
, pp. 829-839
-
-
Sinaiko, A.R.1
Kashtan, C.E.2
Mirkin, B.L.3
-
19
-
-
0023927762
-
Renal failure in sick hypertensive premature infants receiving captopril
-
Tack ED, Perlman JM. Renal failure in sick hypertensive premature infants receiving captopril. J Pediatr. 1988;112:805-810.
-
(1988)
J Pediatr.
, vol.112
, pp. 805-810
-
-
Tack, E.D.1
Perlman, J.M.2
-
20
-
-
0035997150
-
Enalapril Pediatric Hypertension Collaborative Study Group. A double-blind placebo-controlled doseresponse study of the effectiveness and safety of enalapril for children with hypertension
-
Wells T, Frame V, Soffer B, et al; Enalapril Pediatric Hypertension Collaborative Study Group. A double-blind, placebo-controlled, doseresponse study of the effectiveness and safety of enalapril for children with hypertension. J Clin Pharmacol. 2002;42:870-880.
-
(2002)
J Clin Pharmacol.
, vol.42
, pp. 870-880
-
-
Wells, T.1
Frame, V.2
Soffer, B.3
-
21
-
-
0141563380
-
A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension
-
Soffer B, Zhang Z, Miller K, et al. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension. Am J Hypertens. 2003;16:795-800.
-
(2003)
Am J Hypertens.
, vol.16
, pp. 795-800
-
-
Soffer, B.1
Zhang, Z.2
Miller, K.3
-
22
-
-
4444349617
-
Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children?
-
Li JS, Berezny K, Kilaru R, et al. Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children? Hypertension. 2004;44:289-293.
-
(2004)
Hypertension
, vol.44
, pp. 289-293
-
-
Li, J.S.1
Berezny, K.2
Kilaru, R.3
-
23
-
-
42049113033
-
Pediatric antihypertensive trial failures: Analysis of end points and dose range
-
Benjamin DK Jr, Smith PB, Jadhav P, et al. Pediatric antihypertensive trial failures: Analysis of end points and dose range. Hypertension. 2008;51: 834-840.
-
(2008)
Hypertension.
, vol.51
, pp. 834-840
-
-
Benjamin Jr., D.K.1
Smith, P.B.2
Jadhav, P.3
-
24
-
-
33746238819
-
Racial differences are seen in blood pressure response to fosinopril in hypertensive children
-
Menon S, Berezny KY, Kilaru R, et al. Racial differences are seen in blood pressure response to fosinopril in hypertensive children. Am Heart J. 2006;152:394-399.
-
(2006)
Am Heart J.
, vol.152
, pp. 394-399
-
-
Menon, S.1
Berezny, K.Y.2
Kilaru, R.3
-
25
-
-
84855659915
-
-
United States Food and Drug Administration. Summaries of medical and clinical pharmacology reviews. Available at: Accessed October 26, 2010
-
United States Food and Drug Administration. Summaries of medical and clinical pharmacology reviews. Available at: Http://www.fda.gov/Drugs/ DevelopmentApprovalProcess/DevelopmentResources/ucm161894.htm. Accessed October 26, 2010.
-
-
-
-
26
-
-
0037303336
-
Pharmacokinetics of quinapril in children: Assessment during substitution for chronic angiotensin-converting enzyme inhibitor treatment
-
Blumer JL, Daniels SR, Dreyer WJ, et al. Pharmacokinetics of quinapril in children: Assessment during substitution for chronic angiotensin-converting enzyme inhibitor treatment. J Clin Pharmacol. 2003;43:128-132.
-
(2003)
J Clin Pharmacol.
, vol.43
, pp. 128-132
-
-
Blumer, J.L.1
Daniels, S.R.2
Dreyer, W.J.3
-
27
-
-
80051802580
-
Treatment of pediatric hypertension Altace trial II (TOPHAT II). Abstract
-
Falkner B, Pixton G, Portman R, et al. Treatment of pediatric hypertension Altace trial II (TOPHAT II). Abstract. J Clin Hypertens (Greenwich). 2009;11(4 suppl A):A15.
-
(2009)
J Clin Hypertens (Greenwich).
, vol.11
, Issue.4 SUPPL. A
-
-
Falkner, B.1
Pixton, G.2
Portman, R.3
-
28
-
-
20044369154
-
A double-blind, dose-response study of losartan in hypertensive children
-
Shahinfar S, Cano F, Soffer BA, et al. A double-blind, dose-response study of losartan in hypertensive children. Am J Hypertens. 2005;18(2 Pt 1): 183-190.
-
(2005)
Am J Hypertens.
, vol.18
, Issue.2 PART 1
, pp. 183-190
-
-
Shahinfar, S.1
Cano, F.2
Soffer, B.A.3
-
29
-
-
77749277110
-
Randomized, double-blind, controlled study of losartan in children with proteinuria
-
Webb NJ, Lam C, Loeys T, et al. Randomized, double-blind, controlled study of losartan in children with proteinuria. Clin J Am Soc Nephrol. 2010;5:417-424.
-
(2011)
Clin J Am Soc Nephrol.
, vol.5
, pp. 417-424
-
-
Webb, N.J.1
Lam, C.2
Loeys, T.3
-
30
-
-
77952957669
-
Assessment of efficacy and safety of olmesartan in pediatric hypertension study group. A double-blind, dose-response study of the efficacy and safety of olmesartan medoxomil in children and adolescents with hypertension
-
Hazan L, Hernández Rodriguez OA, Bhorat AE, et al; Assessment of Efficacy and Safety of Olmesartan in Pediatric Hypertension Study Group. A double-blind, dose-response study of the efficacy and safety of olmesartan medoxomil in children and adolescents with hypertension. Hypertension. 2010;55:1323-1330.
-
(2011)
Hypertension.
, vol.55
, pp. 1323-1330
-
-
Hazan, L.1
Hernández Rodriguez, O.A.2
Bhorat, A.E.3
-
31
-
-
49849097810
-
Pediatric Valsartan Study Group. Efficacy and safety of the angiotensin receptor blocker valsartan in children with hypertension aged 1 to 5 years
-
Flynn JT, Meyers KE, Neto JP, et al; Pediatric Valsartan Study Group. Efficacy and safety of the angiotensin receptor blocker valsartan in children with hypertension aged 1 to 5 years. Hypertension. 2008;52: 222-228.
-
(2008)
Hypertension.
, vol.52
, pp. 222-228
-
-
Flynn, J.T.1
Meyers, K.E.2
Neto, J.P.3
-
32
-
-
77951286540
-
Candesartan in Children with Hypertension Investigators. Efficacy safety and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of age
-
Schaefer F, van de Walle J, Zurowska A, et al; Candesartan in Children with Hypertension Investigators. Efficacy, safety and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of age. J Hypertens. 2010;28:1083-1090.
-
(2011)
J Hypertens.
, vol.28
, pp. 1083-1090
-
-
Schaefer, F.1
Van De Walle, J.2
Zurowska, A.3
-
33
-
-
58949094116
-
Candesartan in Children with Hypertension (CINCH) Investigators. Efficacy safety and pharmacokinetics of candesartan cilexetil in hypertensive children aged 6 to 17 years
-
Trachtman H, Hainer JW, Sugg J, et al; Candesartan in Children with Hypertension (CINCH) Investigators. Efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive children aged 6 to 17 years. J Clin Hypertens (Greenwich). 2008;10:743-750.
-
(2008)
J Clin Hypertens (Greenwich).
, vol.10
, pp. 743-750
-
-
Trachtman, H.1
Hainer, J.W.2
Sugg, J.3
-
34
-
-
84855687682
-
-
United States Food and Drug Administration, Medical Statistical and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505A and 505B of the Federal Food Drug and Cosmetic Act (the Act) as amended by the FDA Amendments Act of (FDAAA). Available at: Accessed October 26, 2010
-
United States Food and Drug Administration. Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505A and 505B of the Federal Food, Drug, and Cosmetic Act (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA). Available at: Http://www.fda.gov/Drugs/ DevelopmentApprovalProcess/ DevelopmentResources/ucm049872.htm. Accessed October 26, 2010.
-
(2007)
-
-
-
35
-
-
17844374613
-
The pharmacokinetics of irbesartan in hypertensive children and adolescents
-
Sakarcan A, Tenney F, Wilson JT, et al. The pharmacokinetics of irbesartan in hypertensive children and adolescents. J Clin Pharmacol. 2001;41:742-749.
-
(2001)
J Clin Pharmacol.
, vol.41
, pp. 742-749
-
-
Sakarcan, A.1
Tenney, F.2
Wilson, J.T.3
-
36
-
-
0036892741
-
Effectiveness and safety of the angiotensin II antagonist irbesartan in children with chronic kidney diseases
-
Franscini LM, Von Vigier RO, Pfister R, et al. Effectiveness and safety of the angiotensin II antagonist irbesartan in children with chronic kidney diseases. Am J Hypertens. 2002;15:1057-1063.
-
(2002)
Am J Hypertens.
, vol.15
, pp. 1057-1063
-
-
Franscini, L.M.1
Von Vigier, R.O.2
Pfister, R.3
-
37
-
-
77952585357
-
Cough in pediatric patients receiving angiotensin-converting enzyme inhibitor therapy or angiotensin receptor blocker therapy in randomized controlled trials
-
Baker-Smith CM, Benjamin DK Jr, Califf RM, et al. Cough in pediatric patients receiving angiotensin-converting enzyme inhibitor therapy or angiotensin receptor blocker therapy in randomized controlled trials. Clin Pharmacol Ther. 2010;87:668-671.
-
(2011)
Clin Pharmacol Ther.
, vol.87
, pp. 668-671
-
-
Baker-Smith, C.M.1
Benjamin Jr., D.K.2
Califf, R.M.3
-
38
-
-
63849278544
-
Aldosterone-receptor antagonism in hypertension
-
Jansen PM, Danser AH, Imholz BP, et al. Aldosterone-receptor antagonism in hypertension. J Hypertens. 2009;27:680-691.
-
(2009)
J Hypertens.
, vol.27
, pp. 680-691
-
-
Jansen, P.M.1
Danser, A.H.2
Imholz, B.P.3
-
39
-
-
70350686785
-
Role of aldosterone in the progression of chronic kidney disease and potential use of aldosterone blockade in children
-
Ku E, Campese VM. Role of aldosterone in the progression of chronic kidney disease and potential use of aldosterone blockade in children. Pediatr Nephrol. 2009;24:2301-2307.
-
(2009)
Pediatr Nephrol.
, vol.24
, pp. 2301-2307
-
-
Ku, E.1
Campese, V.M.2
-
40
-
-
17644388479
-
Clinical experience with spironolactone in pediatrics
-
Buck ML. Clinical experience with spironolactone in pediatrics. Ann Pharmacother. 2005;39:823-828.
-
(2005)
Ann Pharmacother.
, vol.39
, pp. 823-828
-
-
Buck, M.L.1
-
41
-
-
0141919797
-
Eplerenone: A selective aldosterone blocker
-
Stier CT Jr. Eplerenone: A selective aldosterone blocker. Cardiovasc Drug Rev. 2003;21:169-184.
-
(2003)
Cardiovasc Drug Rev.
, vol.21
, pp. 169-184
-
-
Stier Jr., C.T.1
-
42
-
-
77955285296
-
The efficacy and safety of the novel aldosterone antagonist eplerenone in children with hypertension: A randomized, double-blind, dose-response study
-
Li JS, Flynn JT, Portman R, et al. The efficacy and safety of the novel aldosterone antagonist eplerenone in children with hypertension: A randomized, double-blind, dose-response study. J Pediatr. 2010;157:282-287.
-
(2011)
J Pediatr.
, vol.157
, pp. 282-287
-
-
Li, J.S.1
Flynn, J.T.2
Portman, R.3
-
44
-
-
0017886058
-
Propranolol as an antihypertensive agent in children
-
Griswold WR, McNeal R, Mendoza SA, et al. Propranolol as an antihypertensive agent in children. Arch Dis Child. 1978;53:594-596.
-
(1978)
Arch Dis Child.
, vol.53
, pp. 594-596
-
-
Griswold, W.R.1
McNeal, R.2
Mendoza, S.A.3
-
45
-
-
0021276809
-
Propranolol versus chlorthalidone-a prospective therapeutic trial in children with chronic hypertension
-
Bachmann H. Propranolol versus chlorthalidone-a prospective therapeutic trial in children with chronic hypertension. Helv Paediatr Acta. 1984;39:55-61.
-
(1984)
Helv Paediatr Acta.
, vol.39
, pp. 55-61
-
-
Bachmann, H.1
-
46
-
-
0017875960
-
Oral propranolol treatment in infants and children
-
Gillette P, Garson A Jr, Eterovic E, et al. Oral propranolol treatment in infants and children. J Pediatr. 1978;92:141-144.
-
(1978)
J Pediatr.
, vol.92
, pp. 141-144
-
-
Gillette, P.1
Garson Jr., A.2
Eterovic, E.3
-
47
-
-
0018328624
-
High-dose propranolol therapy in the management of supraventricular tachycardia
-
Pickoff AS, Zies L, Ferrer PL, et al. High-dose propranolol therapy in the management of supraventricular tachycardia. J Pediatr. 1979;94: 144-146.
-
(1979)
J Pediatr.
, vol.94
, pp. 144-146
-
-
Pickoff, A.S.1
Zies, L.2
Ferrer, P.L.3
-
48
-
-
0033571197
-
A cohort study of childhood hypertrophic cardiomyopathy: Improved survival following high-dose beta adrenoceptor antagonist treatment
-
Ostman-Smith I, Wettrell G, Risenfeld T. A cohort study of childhood hypertrophic cardiomyopathy: Improved survival following high-dose beta adrenoceptor antagonist treatment. J Am Coll Cardiol. 1999;34: 1813-1822.
-
(1999)
J Am Coll Cardiol.
, vol.34
, pp. 1813-1822
-
-
Ostman-Smith, I.1
Wettrell, G.2
Risenfeld, T.3
-
49
-
-
0033511314
-
Propranolol in prevention of portal hypertensive hemorrhage in children: A pilot study
-
Shashidar H, Langhans N, Grand RJ. Propranolol in prevention of portal hypertensive hemorrhage in children: A pilot study. J Pediatr Gastroenterol Nutr. 1999;29:12-17.
-
(1999)
J Pediatr Gastroenterol Nutr.
, vol.29
, pp. 12-17
-
-
Shashidar, H.1
Langhans, N.2
Grand, R.J.3
-
50
-
-
0020570631
-
Successful treatment of supraventricular tachycardia with metoprolol, a cardioselective beta blocker
-
Hepner SI, Davoli E. Successful treatment of supraventricular tachycardia with metoprolol, a cardioselective beta blocker. Clin Pediatr. 1983;22: 522-523.
-
(1983)
Clin Pediatr.
, vol.22
, pp. 522-523
-
-
Hepner, S.I.1
Davoli, E.2
-
51
-
-
0032948208
-
Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: A multi-institutional experience
-
Shaddy RE. Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: A multi-institutional experience. J Heart Lung Transplant. 1999;18:269-274.
-
(1999)
J Heart Lung Transplant.
, vol.18
, pp. 269-274
-
-
Shaddy, R.E.1
-
52
-
-
0029896205
-
Long-term efficacy and safety of atenolol for supraventricular tachycardia in children
-
Mehta AV, Subrahmanyam AB, Anand R. Long-term efficacy and safety of atenolol for supraventricular tachycardia in children. Pediatr Cardiol. 1996;17:231-236.
-
(1996)
Pediatr Cardiol.
, vol.17
, pp. 231-236
-
-
Mehta, A.V.1
Subrahmanyam, A.B.2
Anand, R.3
-
53
-
-
0029154278
-
Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope
-
ScottWA, Pongiglione G, Bromberg BI, et al. Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol. 1995;76:400-402.
-
(1995)
Am J Cardiol.
, vol.76
, pp. 400-402
-
-
Scott, W.A.1
Pongiglione, G.2
Bromberg, B.I.3
-
54
-
-
0025225280
-
Atenolol therapy for exerciseinduced hypertension after aortic coarctation repair
-
Kavey RE, Cotton JL, Backman MS. Atenolol therapy for exerciseinduced hypertension after aortic coarctation repair. Am J Cardiol. 1990; 66:1233-1236.
-
(1990)
Am J Cardiol.
, vol.66
, pp. 1233-1236
-
-
Kavey, R.E.1
Cotton, J.L.2
Backman, M.S.3
-
55
-
-
0024820721
-
Pharmacokinetics and pharmacodynamics of atenolol in children
-
Buck ML, Wiest D, Gillette PC, et al. Pharmacokinetics and pharmacodynamics of atenolol in children. Clin Pharmacol Ther. 1989;46:629-633.
-
(1989)
Clin Pharmacol Ther.
, vol.46
, pp. 629-633
-
-
Buck, M.L.1
Wiest, D.2
Gillette, P.C.3
-
56
-
-
33846344318
-
Efficacy and safety of extended release metoprolol succinate in hypertensive children 6 to 16 years of age: A clinical trial experience
-
Toprol-XL Pediatric Hypertension Investigators 139.e1
-
Batisky DL, Sorof JM, Sugg J, et al; Toprol-XL Pediatric Hypertension Investigators. Efficacy and safety of extended release metoprolol succinate in hypertensive children 6 to 16 years of age: A clinical trial experience. J Pediatr. 2007;150:134-139, 139.e1.
-
(2007)
J Pediatr.
, vol.150
, pp. 134-139
-
-
Batisky, D.L.1
Sorof, J.M.2
Sugg, J.3
-
57
-
-
0028300179
-
Bisoprolol, a once-a-day beta-blocking agent for patients with mild to moderate hypertension
-
Davidov ME, Singh SP, Vlachakis ND, et al. Bisoprolol, a once-a-day beta-blocking agent for patients with mild to moderate hypertension. Clin Cardiol. 1994;17:263-268.
-
(1994)
Clin Cardiol.
, vol.17
, pp. 263-268
-
-
Davidov, M.E.1
Singh, S.P.2
Vlachakis, N.D.3
-
58
-
-
0036935258
-
Beta-blocker/thiazide combination for treatment of hypertensive children: A randomized double-blind, placebocontrolled trial
-
Sorof JM, Cargo P, Graepel J, et al. Beta-blocker/thiazide combination for treatment of hypertensive children: A randomized double-blind, placebocontrolled trial. Pediatr Nephrol. 2002;17:345-350.
-
(2002)
Pediatr Nephrol.
, vol.17
, pp. 345-350
-
-
Sorof, J.M.1
Cargo, P.2
Graepel, J.3
-
59
-
-
0026512515
-
Intravenously administered labetalol for treatment of hypertension in children
-
Bunchman TE, Lynch RE, Wood EG. Intravenously administered labetalol for treatment of hypertension in children. J Pediatr. 1992;120:140-144.
-
(1992)
J Pediatr.
, vol.120
, pp. 140-144
-
-
Bunchman, T.E.1
Lynch, R.E.2
Wood, E.G.3
-
60
-
-
34548570632
-
Carvedilol for children and adolescents with heart failure: A randomized controlled trial
-
Pediatric Carvedilol Study Group
-
Shaddy RE, Boucek MM, Hsu DT, et al; Pediatric Carvedilol Study Group. Carvedilol for children and adolescents with heart failure: A randomized controlled trial. JAMA. 2007;298:1171-1179.
-
(2007)
JAMA
, vol.298
, pp. 1171-1179
-
-
Shaddy, R.E.1
Boucek, M.M.2
Hsu, D.T.3
-
61
-
-
0033638940
-
Calcium channel blockers: Pharmacology and place in therapy of pediatric hypertension
-
Flynn JT, Pasko DA. Calcium channel blockers: Pharmacology and place in therapy of pediatric hypertension. Pediatr Nephrol. 2000;15:302-316.
-
(2000)
Pediatr Nephrol.
, vol.15
, pp. 302-316
-
-
Flynn, J.T.1
Pasko, D.A.2
-
62
-
-
0025891229
-
Verapamil and migraine prophylaxis: Mechanisms and efficacy
-
Markley HG. Verapamil and migraine prophylaxis: Mechanisms and efficacy. Am J Med. 1991;90:S48-S53.
-
(1991)
Am J Med.
, vol.90
-
-
Markley, H.G.1
-
63
-
-
23944512872
-
Renoprotective effect of diltiazem in hypertensive type 2 diabetic patients with persistent microalbuminuria despite ACE inhibitor treatment
-
Pérez-Maraver M, Carrera MJ, MicalóT, et al. Renoprotective effect of diltiazem in hypertensive type 2 diabetic patients with persistent microalbuminuria despite ACE inhibitor treatment. Diabetes Res Clin Pract. 2005;70:13-19.
-
(2005)
Diabetes Res Clin Pract.
, vol.70
, pp. 13-19
-
-
Pérez-Maraver, M.1
Carrera, M.J.2
Micaló, T.3
-
64
-
-
67650293226
-
Severe hypertension in children and adolescents: Pathophysiology and treatment
-
Flynn JT, Tullus K. Severe hypertension in children and adolescents: Pathophysiology and treatment. Pediatr Nephrol. 2009;24:1101-1112.
-
(2009)
Pediatr Nephrol.
, vol.24
, pp. 1101-1112
-
-
Flynn, J.T.1
Tullus, K.2
-
65
-
-
0029025965
-
A crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension
-
Moncica I, Oh PI, ul Qamar I, et al. A crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension. Arch Dis Child. 1995;73:154-156.
-
(1995)
Arch Dis Child.
, vol.73
, pp. 154-156
-
-
Moncica, I.1
Oh, P.I.2
Ul Qamar, I.3
-
66
-
-
0032719823
-
Use of calcium-channel blockers in pediatric renal transplant recipients
-
Silverstein DM, Palmer J, Baluarte HJ, et al. Use of calcium-channel blockers in pediatric renal transplant recipients. Pediatr Transplant. 1999; 3:288-292.
-
(1999)
Pediatr Transplant.
, vol.3
, pp. 288-292
-
-
Silverstein, D.M.1
Palmer, J.2
Baluarte, H.J.3
-
67
-
-
0034063328
-
Initial experience with isradipine for the treatment of hypertension in children
-
Strauser LM, Groshong T, Tobias JD. Initial experience with isradipine for the treatment of hypertension in children. South Med J. 2000;93:287-293.
-
(2000)
South Med J.
, vol.93
, pp. 287-293
-
-
Strauser, L.M.1
Groshong, T.2
Tobias, J.D.3
-
68
-
-
0036947341
-
Isradipine treatment of hypertension in children: A single-center experience
-
Flynn JT, Warnick SJ. Isradipine treatment of hypertension in children: A single-center experience. Pediatr Nephrol. 2002;17:748-753.
-
(2002)
Pediatr Nephrol.
, vol.17
, pp. 748-753
-
-
Flynn, J.T.1
Warnick, S.J.2
-
69
-
-
0028033659
-
Stability of isradipine in an extemporaneously compounded oral liquid
-
MacDonald JL, Johnson CE, Jacobson P. Stability of isradipine in an extemporaneously compounded oral liquid. Am J Hosp Pharm. 1994;51: 2409-2411.
-
(1994)
Am J Hosp Pharm.
, vol.51
, pp. 2409-2411
-
-
MacDonald, J.L.1
Johnson, C.E.2
Jacobson, P.3
-
70
-
-
78249265347
-
Isradipine treatment of acute hypertension in hospitalized children and adolescents
-
Miyashita Y, Peterson D, Rees JM, et al. Isradipine treatment of acute hypertension in hospitalized children and adolescents. J Clin Hypertens (Greenwich). 2010;12:850-855.
-
(2011)
J Clin Hypertens (Greenwich).
, vol.12
, pp. 850-855
-
-
Miyashita, Y.1
Peterson, D.2
Rees, J.M.3
-
71
-
-
0037484252
-
Clinical trial of extended-release felodipine in pediatric essential hypertension
-
Trachtman H, Frank R, Mahan JD, et al. Clinical trial of extended-release felodipine in pediatric essential hypertension. Pediatr Nephrol. 2003;18: 548-753.
-
(2003)
Pediatr Nephrol.
, vol.18
, pp. 548-753
-
-
Trachtman, H.1
Frank, R.2
Mahan, J.D.3
-
75
-
-
4444363007
-
A randomized, placebo-controlled trial of amlodipine in children with hypertension
-
For the PATH-1 Investigators
-
Flynn JT, Newburger JW, Daniels SR, et al; For the PATH-1 Investigators. A randomized, placebo-controlled trial of amlodipine in children with hypertension. J Pediatr. 2004;145:353-359.
-
(2004)
J Pediatr.
, vol.145
, pp. 353-359
-
-
Flynn, J.T.1
Newburger, J.W.2
Daniels, S.R.3
-
76
-
-
33745908609
-
Population pharmacokinetics of amlodipine in hypertensive children and adolescents
-
For the PATH-2 Investigators
-
Flynn JT, Nahata MC, Mahan JD, et al; For the PATH-2 Investigators. Population pharmacokinetics of amlodipine in hypertensive children and adolescents. J Clin Pharmacol. 2006;46:905-916.
-
(2006)
J Clin Pharmacol.
, vol.46
, pp. 905-916
-
-
Flynn, J.T.1
Nahata, M.C.2
Mahan, J.D.3
-
77
-
-
0033128383
-
Stability of amlodipine besylate in two liquid dosage forms
-
Nahata MC, Morosco RS, Hipple TF. Stability of amlodipine besylate in two liquid dosage forms. J Am Pharm Assoc. 1999;39:375-377.
-
(1999)
J Am Pharm Assoc.
, vol.39
, pp. 375-377
-
-
Nahata, M.C.1
Morosco, R.S.2
Hipple, T.F.3
-
78
-
-
0020967629
-
Severe hypertension in children with renal disease: Treatment with minoxidil
-
Puri HC, Maltz HE, Kaiser BA, et al. Severe hypertension in children with renal disease: Treatment with minoxidil. Am J Kid Dis. 1983;3:71-75.
-
(1983)
Am J Kid Dis.
, vol.3
, pp. 71-75
-
-
Puri, H.C.1
Maltz, H.E.2
Kaiser, B.A.3
-
79
-
-
0022971840
-
Minoxidil for control of acute blood pressure elevation in chronically hypertensive children
-
Strife CF, Quinlan M, Waldo FB, et al. Minoxidil for control of acute blood pressure elevation in chronically hypertensive children. Pediatrics. 1986;78:861-865.
-
(1986)
Pediatrics.
, vol.78
, pp. 861-865
-
-
Strife, C.F.1
Quinlan, M.2
Waldo, F.B.3
-
80
-
-
0020673685
-
The use of clonidine monotherapy in adolescent hypertension
-
Falkner B, Onesti G, Lowenthal DT, et al. The use of clonidine monotherapy in adolescent hypertension. Chest. 1983;83(2 suppl):425-427.
-
(1983)
Chest.
, vol.83
, Issue.2 SUPPL.
, pp. 425-427
-
-
Falkner, B.1
Onesti, G.2
Lowenthal, D.T.3
-
81
-
-
0022315323
-
Transdermal clonidine in the treatment of adolescent hypertension
-
Falkner B, Thanki B, Lowenthal DT. Transdermal clonidine in the treatment of adolescent hypertension. J Hypertens Suppl. 1985;3:S61-S63.
-
(1985)
J Hypertens Suppl.
, vol.3
-
-
Falkner, B.1
Thanki, B.2
Lowenthal, D.T.3
-
82
-
-
57649200115
-
Extemporaneous drug formulations
-
Nahata MC, Allen LV Jr. Extemporaneous drug formulations. Clin Ther. 2008;30:2112-2119.
-
(2008)
Clin Ther.
, vol.30
, pp. 2112-2119
-
-
Nahata, M.C.1
Allen Jr., L.V.2
-
83
-
-
0038460302
-
National heart lung and blood institute joint national committee on prevention detection evaluation and treatment of high blood pressure; national high blood pressure education program coordinating committee. The seventh report of the joint national committee on prevention detection evaluation and treatment of high blood pressure: The jnc 7 report
-
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003;289:2560-2572.
-
(2003)
JAMA
, vol.289
, pp. 2560-2572
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
Cushman, W.C.4
Green, L.A.5
Izzo Jr., J.L.6
Jones, D.W.7
Materson, B.J.8
Oparil, S.9
Wright Jr., J.T.10
Roccella, E.J.11
-
84
-
-
77957018973
-
Treating the causes of paediatric hypertension using non-invasive physiological parameters
-
Brierley J, Marks SD. Treating the causes of paediatric hypertension using non-invasive physiological parameters. Med Hypoth. 2010;75:439-441.
-
(2011)
Med Hypoth.
, vol.75
, pp. 439-441
-
-
Brierley, J.1
Marks, S.D.2
-
85
-
-
0035653863
-
Abstract, closing summary, and table of contents for Laragh's 25 lessons in pathophysiology and 12 clinical pearls for treating hypertension
-
Laragh JH. Abstract, closing summary, and table of contents for Laragh's 25 lessons in pathophysiology and 12 clinical pearls for treating hypertension. Am J Hypertens. 2001;14:1173-1177.
-
(2001)
Am J Hypertens.
, vol.14
, pp. 1173-1177
-
-
Laragh, J.H.1
-
86
-
-
79952405304
-
Relationship of renin and aldosterone to ambulatory blood pressure in obese adolescents
-
doi: 10.1203/ PDR.0b013e31820bd148
-
Shatat IF, Flynn JT. Relationship of renin and aldosterone to ambulatory blood pressure in obese adolescents. Pediatr Res. 2001; doi: 10.1203/ PDR.0b013e31820bd148.
-
(2001)
Pediatr Res.
-
-
Shatat, I.F.1
Flynn, J.T.2
-
87
-
-
70350454952
-
European Society of Hypertension. Management of high blood pressure in children and adolescents: Recommendations of the European Society of Hypertension
-
Lurbe E, Cifkova R, Cruickshank JK, et al; European Society of Hypertension. Management of high blood pressure in children and adolescents: Recommendations of the European Society of Hypertension. J Hypertens. 2009;27:1719-1742.
-
(2009)
J Hypertens.
, vol.27
, pp. 1719-1742
-
-
Lurbe, E.1
Cifkova, R.2
Cruickshank, J.K.3
-
88
-
-
27644489501
-
HOme MEasuRement of blood pressure study group. Self-monitoring of blood pressure promotes achievement of blood pressure target in primary health care
-
Halme L, Vesalainen R, Kaaja M, et al; HOme MEasuRement of blood pressure study group. Self-monitoring of blood pressure promotes achievement of blood pressure target in primary health care. Am J Hypertens. 2005;18:1415-1420.
-
(2005)
Am J Hypertens.
, vol.18
, pp. 1415-1420
-
-
Halme, L.1
Vesalainen, R.2
Kaaja, M.3
-
89
-
-
46449089182
-
American heart association american society of hypertension and preventive cardiovascular nurses association. call to action on use and reimbursement for home blood pressure monitoring: A joint scientific statement from the american heart association, american society of hypertension, and preventive cardiovascular nurses association
-
Pickering TG, Miller NH, Ogedegbe G, et al; American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Call to action on use and reimbursement for home blood pressure monitoring: A joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52:1-9.
-
(2008)
Hypertension.
, vol.52
, pp. 1-9
-
-
Pickering, T.G.1
Miller, N.H.2
Ogedegbe, G.3
-
90
-
-
70350441308
-
Home blood pressure monitoring in children and adolescents: A systematic review
-
Stergiou GS, Karpettas N, Kapoyiannis A, et al. Home blood pressure monitoring in children and adolescents: A systematic review. J Hypertens. 2009;27:1941-1947.
-
(2009)
J Hypertens.
, vol.27
, pp. 1941-1947
-
-
Stergiou, G.S.1
Karpettas, N.2
Kapoyiannis, A.3
-
91
-
-
18644372039
-
How are hypertensive children evaluated and managed? A survey of North American pediatric nephrologists
-
Woroniecki RP, Flynn JT. How are hypertensive children evaluated and managed? A survey of North American pediatric nephrologists. Pediatr Nephrol. 2005;20:791-797.
-
(2005)
Pediatr Nephrol.
, vol.20
, pp. 791-797
-
-
Woroniecki, R.P.1
Flynn, J.T.2
-
92
-
-
33744966030
-
Major congenital malformations after first-trimester exposure to ACE inhibitors
-
Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354:2443-2451.
-
(2006)
N Engl J Med.
, vol.354
, pp. 2443-2451
-
-
Cooper, W.O.1
Hernandez-Diaz, S.2
Arbogast, P.G.3
|